Official Publications Celltrion, Inc.

Equities

End-of-day quote Korea S.E. Other stock markets 12/02/2026			5-day change	1st Jan Change
238,500.00 ^KRW	-0.42%		+11.19%	+31.77%

02-05	CVS Health to drop Amgen and Lilly's bone disease treatments from some drug lists (February 5)	RE
01-30	Celltrion Launches Autoimmune Drug Aptozma in Europe	MT

No official publication found